Clinical Trial Results:
A EUROPEAN MULTICENTER OPEN-LABEL RANDOMIZED TRIAL TO EVALUATE THE REDUCTION OF ISCHEMIA / REPERFUSION INJURY AFTER DE NOVO SIMULTANEOUS PANCREAS/KIDNEY TRANSPLANTATION IN TYPE 1-DIABETIC PATIENTS COMPARING A CONTROL GROUP VERSUS TREATMENT WITH PER-OPERATIVE N ACETYLCYSTEINE AND ANTITHROMBIN III VERSUS N ACETYLCYSTEINE ALONE
Summary
|
|
EudraCT number |
2007-003728-39 |
Trial protocol |
BE |
Global completion date |
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
24 Jan 2021
|
First version publication date |
24 Jan 2021
|
Other versions |
|
Summary report(s) |
trial never started reasons |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.